Plain-English translation of NCT07814079 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a precise surgical approach to treat ventricular tachycardia (VT), a serious and potentially life-threatening irregular heartbeat that occurs in people with scarring or damage to the heart. Using advanced mapping technology, doctors will identify the exact scar channels causing the irregular rhythm, then use targeted ablation energy to block those specific pathways and restore normal heartbeat.
Current VT ablation procedures can be difficult to target accurately, sometimes requiring extensive treatment of large areas of scar tissue. This trial is designed to see if a more focused approach—isolating only the specific channels causing the dangerous rhythm—can be more effective and safer for patients with structural heart disease.
You likely qualify if…
You likely don't qualify if…
You will undergo a specialized heart catheterization procedure in which doctors use advanced mapping technology to identify the exact scar channels causing your irregular heartbeats. Once these channels are precisely located both noninvasively and with catheters inside your heart, targeted ablation energy will be delivered to block the exits of these pathways. After the treatment, doctors will test whether your heart can still be triggered into the dangerous rhythm—if it can, additional ablation may be performed based on standard mapping techniques.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States